NCT06224517 Pulse Wave Velocity and in Subacute Stroke Patients Following Rehabilitation
| NCT ID | NCT06224517 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shin Kong Wu Ho-Su Memorial Hospital |
| Condition | Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2025-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2024-02-01 with a primary completion date of 2025-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Currently, the literature regarding the relationship between Pulse Wave Velocity (PWV) and functional recovery, particularly of upper limb function, in patients with subacute stroke is still limited. Therefore, the aim of the study is to evaluate the changes in baPWV after four weeks of intensive rehabilitation therapy, and the correlation between these changes and functional recovery.
Eligibility Criteria
Inclusion Criteria: * First-onset cerebral ischemic stroke within the previous 3 months, which is confirmed clinically by computed tomography scans or magnetic resonance imaging * Sufficient cognition to understand procedures and provide informed consent. Exclusion Criteria: * Hemorrhagic stroke, cerebellar or brainstem lesions which may affect autonomic or balance * Concurrent neurological or neurodegenerative diseases (e.g. Parkinson's disease, multiple sclerosis, etc.) * Brain tumor * Malignancy * Limb deficiency or amputation
Contact & Investigator
Ying-Chen Kuo, MD
PRINCIPAL INVESTIGATOR
Shin Kong Wu Ho-Su Memorial Hospital
Frequently Asked Questions
Who can join the NCT06224517 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06224517 currently recruiting?
Yes, NCT06224517 is actively recruiting participants. Contact the research team at allazure1121@gmail.com for enrollment information.
Where is the NCT06224517 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06224517 clinical trial?
NCT06224517 is sponsored by Shin Kong Wu Ho-Su Memorial Hospital. The principal investigator is Ying-Chen Kuo, MD at Shin Kong Wu Ho-Su Memorial Hospital. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.